Cationic surface modification of gold nanoparticles for enhanced cellular uptake and X-ray radiation therapy
作者:Chaoming Wang、An Sun、Yong Qiao、Peipei Zhang、Liyuan Ma、Ming Su
DOI:10.1039/c5tb00766f
日期:——
Gold nanoparticles with cationic surface modification can enhance X-ray radiation therapy by enhancing cellular uptake.
具有阳离子表面修饰的金纳米颗粒可以通过增强细胞摄取来增强X射线放疗的效果。
Quantitative Replacement of Cetyl Trimethylammonium Bromide by Cationic Thiol Ligands on the Surface of Gold Nanorods and Their Extremely Large Uptake by Cancer Cells
作者:Leonid Vigderman、Pramit Manna、Eugene R. Zubarev
DOI:10.1002/anie.201107304
日期:2012.1.16
Stable and biocompatible: The chemical composition of synthesized cationic thiolate‐monolayer‐protected goldnanorods was precisely determined. In vitro cell culture experiments showed no cytotoxicity of these nanorods, and the number of nanorods that were taken up by each cancercell exceeded two million particles (see picture).
METHIONINE METABOLITES PREDICT AGGRESSIVE CANCER PROGRESSION
申请人:Cedars-Sinai Medical Center
公开号:EP2882862A2
公开(公告)日:2015-06-17
METHODS AND APPARATUSES FOR SURFACE FUNCTIONALIZATION AND COATING OF NANOCRYSTALS
申请人:Nikoobakht Babak
公开号:US20150038578A1
公开(公告)日:2015-02-05
The present disclosure describes a method and series of compositions for surface functionalization of nanoparticles that eliminates the possibility of ligand loss in alien environments. In particular, the present disclosure provides method and compositions for production of highly-stable surface-functionalized nanorods of noble metals for in-vivo applications as well as use in composite materials.
[EN] METHIONINE METABOLITES PREDICT AGGRESSIVE CANCER PROGRESSION<br/>[FR] LES MÉTABOLITES DE LA MÉTHIONINE PRÉDISENT LA PROGRESSION D'UN CANCER AGRESSIF
申请人:CEDARS SINAI MEDICAL CENTER
公开号:WO2014026157A2
公开(公告)日:2014-02-13
The invention relates to the use of enzymes, nanorods, and nanoelectronic devices to detect cysteine level in a patient sample and relates to the use of the detected cysteine level to predict cancer recurrence in the patient and to prescribe and/or administer an appropriate therapy to a subject. The invention is directed to systems and methods of detecting cysteine level in a sample from a subject, wherein the systems or methods can further comprise measuring at least one additional parameter, such as PSA level, Gleason score and clinical stage. The invention is directed to systems and methods of predicting the probability of a recurrence of a cancer in a subject, wherein the systems or methods can further comprise measuring at least one additional parameter, such as PSA level, Gleason score and clinical stage. The invention further comprises prescribing and/or administering an appropriate therapy to a subject based on the predicted probability of recurrence.